Cerebral Aneurysms Global Clinical Trials Review, H1, 2016
Summary
GlobalDatas clinical trial report, Cerebral Aneurysms Global Clinical Trials Review, H1, 2016 provides an overview of Cerebral Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Cerebral Aneurysms Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 35
Abbreviations 35
Definitions 35
Research Methodology 36
Secondary Research 36
About GlobalData 37
Contact Us 37
Disclaimer 37
Source 38
List Of Tables
List of Tables
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region, 2016* 5
Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Cerebral Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
List Of Figures
List of Figures
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 25
GlobalData Methodology 36
